How should tick-borne cutaneous infections be diagnosed and managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Diagnosis and Treatment of Tick-Borne Skin Diseases

Start doxycycline immediately when you suspect a tick-borne rickettsial disease based on clinical presentation—do not wait for laboratory confirmation, as delay in treatment can lead to severe disease and death. 1

Clinical Diagnosis

Key Presenting Features

Suspect tick-borne rickettsial disease when patients present with:

  • Acute onset of high fever, shaking chills, severe headache, and generalized myalgias
  • Timing: Symptoms typically 2-14 days after tick exposure during April-September
  • Geographic risk: South Atlantic, north central, south central, and New England states 2

Critical caveat: Only 60% of Rocky Mountain spotted fever (RMSF) patients and 68% of ehrlichiosis patients recall a tick bite—absence of tick exposure history should never exclude the diagnosis 2

Rash Characteristics by Disease

Rocky Mountain Spotted Fever (RMSF):

  • Rash appears 2-4 days after fever onset (most patients seek care before rash develops) 2
  • Begins as small, blanching, pink macules on ankles, wrists, or forearms
  • Evolves to maculopapules, then petechiae in 50% of cases
  • Spreads centrally to involve entire body including palms and soles
  • Warning: Rash is completely absent in up to 20% of RMSF cases 2
  • Classic petechial rash appears day 5-6 and indicates severe disease progression 2

Ehrlichiosis:

  • Rash in only one-third of adults (up to 66% in children) 2
  • Appears later (median 5 days after onset)
  • Variable patterns: petechial, maculopapular, or diffuse erythema 2
  • Rarely involves palms and soles 2

Anaplasmosis:

  • Rash is rare 2

Laboratory Clues

Look for these abnormalities that distinguish tick-borne diseases from viral illnesses:

  • Thrombocytopenia
  • Leukopenia
  • Anemia
  • Elevated liver enzymes
  • Hyponatremia 3, 4

Specific Diagnostic Tests

Do not delay treatment while awaiting results 1

Acute Phase (First Week):

  • PCR on whole blood: Most sensitive for ehrlichiosis and anaplasmosis; less sensitive for RMSF but improves in severe disease 1
  • Blood smear microscopy: Look for morulae (intracellular inclusions) in leukocytes—highly suggestive of ehrlichiosis/anaplasmosis but insensitive 1
  • Skin biopsy with immunostaining: For spotted fever group rickettsioses, biopsy rash or eschar for immunostaining or PCR 1

Confirmatory Testing:

  • Indirect immunofluorescence antibody (IFA) assay: Reference standard using paired sera (acute and 2-4 weeks convalescent) showing ≥4-fold rise in titer 1
  • Critical limitation: Patients lack diagnostic antibody titers during the first week—negative acute serology does not exclude disease 1

Treatment Algorithm

First-Line Treatment: Doxycycline for ALL Patients

Doxycycline is the drug of choice for all tick-borne rickettsial diseases in children and adults, including children <8 years old 1

Dosing:

  • Adults: 100 mg twice daily
  • Children: Standard pediatric dosing
  • Duration: Continue until patient is afebrile for 24-48 hours

Expected Response:

  • Fever should resolve within 48 hours of starting doxycycline
  • If fever persists >48 hours, consider alternative diagnosis or coinfection 1

Special Populations

Pregnant Women:

  • Use doxycycline for RMSF and E. chaffeensis ehrlichiosis—disease-related risks to mother and fetus outweigh theoretical teratogenic risk 1
  • Data suggest treatment at recommended dose/duration is unlikely to pose substantial teratogenic risk 1
  • Chloramphenicol may be alternative for RMSF only (NOT for ehrlichiosis/anaplasmosis), but has higher mortality risk than doxycycline 1
  • Rifampin may be considered for mild anaplasmosis during pregnancy 1

Lactating Women:

  • Short-term doxycycline use is considered probably safe during lactation 1

Severe Doxycycline Allergy:

  • RMSF: Chloramphenicol (but higher death risk than doxycycline) 1
  • Anaplasmosis (mild cases): Rifampin 1
  • Ehrlichiosis: No acceptable alternative to doxycycline 1

What NOT to Do

Do NOT give prophylactic antibiotics after tick bite in asymptomatic patients—available data do not support this practice for rickettsial diseases 1

Do NOT treat asymptomatic seropositive patients—antibodies persist for months to years after infection regardless of treatment 1

Prevention Counseling

Tick Removal Technique:

  • Use tweezers or fine-tipped forceps (not bare fingers)
  • Grasp tick close to skin and pull back/upward with constant pressure
  • Never use gasoline, kerosene, petroleum jelly, nail polish, or matches 1
  • Clean bite area with soap and water, alcohol, or iodine scrub 1

Protective Measures:

  • DEET, IR3535, or picaridin-containing EPA-registered repellents 1
  • Long-sleeved shirts, pants, socks, closed-toe shoes
  • Permethrin-treated clothing reduces tick bites by >80% 1
  • Regular tick checks on persons and pets 1
  • Pet ectoparasite control products (topical acaricides, tick collars) 1

Common Pitfalls

  1. Waiting for rash: Most RMSF patients present before rash develops; 20% never develop rash 2
  2. Requiring tick bite history: Majority don't recall tick exposure 2
  3. Delaying treatment for test results: Start doxycycline based on clinical suspicion alone 1
  4. Avoiding doxycycline in children <8 years: This is the recommended treatment by AAP and CDC for all ages 1
  5. Using chloramphenicol for ehrlichiosis/anaplasmosis: Not acceptable—only doxycycline works 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.